
Arisan Therapeutics: A life science company developing treatments for impactful viral diseases.
Arisan Therapeutics, founded in Carlsbad, CA, is a life science company dedicated to the discovery and development of novel therapeutics for neglected and emerging viral diseases. The company's core mission is to address infectious diseases with significant public health impacts, particularly those classified as priority biodefense-related pathogens. Arisan Therapeutics focuses on creating innovative solutions that can mitigate the threats posed by these diseases, thereby improving global health outcomes.
Notable figures associated with Arisan Therapeutics include leading scientists and industry experts in virology and drug development. The company has garnered attention from key investors in the biotech sector, which has enabled it to advance its research and development efforts. Arisan Therapeutics has achieved significant milestones in preclinical studies, demonstrating the potential efficacy of its therapeutic candidates. The overall impact of Arisan Therapeutics lies in its commitment to combating viral diseases that are often overlooked, contributing to the broader field of infectious disease treatment and prevention.
Companies similar to Arisan Therapeutics include Aristea Therapeutics, Iaso Therapeutics, Antios Therapeutics and Globavir Biosciences.
Arisan Therapeutics was founded in 2010.
Arisan Therapeutics' headquarters is located in San Diego, CA, US.
Arisan Therapeutics' most recent funding round was for $1M (USD) in June 2019.
As of Jun 27, 2019, Arisan Therapeutics has disclosed funding of $1M (USD). Undisclosed round amounts are excluded.
Arisan Therapeutics has 7 employees as of Feb 5, 2024.
Globavir Biosciences